Not all the quality-control problems the Food and Drug Administration found in 2018 during its most recent inspection of ABH Nature’s Products Inc. were repeats, but one dated to the first inspection of the contract manufacturer in 2010 and others were noted since 2012.
New York Supplement Firm Shut Down On GMP Violations Repeated Since 2010
ABH Nature’s and its owner, Mohammed Jahirul Islam, agree to a consent decree recently barring them from distributing adulterated and misbranded supplements and unapproved and misbranded drugs and requiring remedial action before restarting production. FDA records indicate its s inspections of the facilities began in 2010 and at least one GMP violation found in later inspections was noted in the first.
More from Regulation
• By
European Food Safety Authority finds no cause and effect relationship between Givaudan's Pacran supplement and defense against urinary tract infections.
• By
Manufacturers, marketers and other businesses in the industry may be thinking, “Well, this is different” because the president ordered tariffs on a list of countries rather than on his sole first-term target of China.
• By
Tariffs on imports from China and look at eliminating self-affirmed GRAS pathway introduced under Trump while DoJ Consumer Protection Branch also continues supplement sector priorities enduring across administrations.
• By
Sales of Bioventra’s probiotic put inventory at “a critical low” as “parallel rise in unverified listings on third-party marketplaces prompted concern among” customers. DoJ and food and drug industry attorney say counterfeiting remains a problem in supplement sector.